Retatrutide Study Targets Obesity Without Type 2 Diabetes | Retatrutide News

The Phase 2 trial for retatrutide (LY3437943) targets obesity in adults without type 2 diabetes. It is a double-blind, placebo-controlled study involvin...
Clinical Trials · October 22, 2026